/In Vitro Diagnostics
Diagnostics company Health Discovery Corp. has granted Abbott Molecular exclusive worldwide rights (including a sublicense option) to develop and commercialize its tissue- and urine-based tests for prostate cancer. (Feb.)...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?